期刊文献+

盐酸多巴胺注射液与注射用托拉塞米的配伍稳定性考察 被引量:2

Stability of Dopamine Hydrochloride Injection Mixed with Torasemide for Injection
下载PDF
导出
摘要 目的:考察盐酸多巴胺注射液与注射用托拉塞米的配伍稳定性。方法:采用液相色谱法,对盐酸多巴胺注射液与注射用托拉塞米的配伍液进行定性和定量分析,考察其配伍液的稳定性变化。结果:两种药物混合后出现颜色变化;注射用托拉塞米峰面积响应值未见明显变化,而盐酸多巴胺峰面积响应值明显下降,提示盐酸多巴胺可能发生了化学反应。结论:在治疗顽固性心衰时,虽然托拉塞米与盐酸多巴胺联用有较好的疗效,但在应用时应注意两药存在配伍禁忌,避免在同一静脉通道内静脉滴注。 Objective: To study the stability of dopamine hydrochloride injection mixed with torasemide for injection, Methods: By liquid chromatography, dopamine hydrochloride injection and compatible with torasemide solution were analyzed qualitatively and quantitatively. Results: After few hours, the colour of mixture was changed. The area of torasemide had no significant change, but the area of dopamine significantly decreased .Thus we consider that do- pamine may produce some chemical reactions. Conclusion: Although in the treatment of intractable heart failure, com- bining torasemide with dopamine always brings good result, we should pay attention to the incompatibility, So we should avoid using them at the same time and in the same vein channel.
出处 《抗感染药学》 2015年第6期824-827,共4页 Anti-infection Pharmacy
基金 江西省卫生计生委中医药科研课题(编号:2014A174)
关键词 盐酸多巴胺 注射用托拉塞米 配伍禁忌 稳定性 dopamine hydrochloride torasemide for injection stability
  • 相关文献

参考文献6

二级参考文献19

  • 1蒋文,李一石,华潞,黄岩,刘晗,苏绮,王蓓,成小如,张阴凤.托拉塞米的利尿作用和安全性[J].中国临床药理学杂志,2004,20(6):416-419. 被引量:16
  • 2吴燕琼,梁洁雯.HPLC测定盐酸多巴胺注射液的含量[J].广东药学,2005,15(3):15-17. 被引量:12
  • 3胡大一,吴彦.规范心力衰竭治疗 加强患者管理[J].中华心血管病杂志,2005,33(6):495-497. 被引量:124
  • 4彭东明,黄可龙,刘艳飞,刘璐璐.高效液相色谱法测定注射用布美他尼含量[J].中国现代应用药学,2006,23(5):404-406. 被引量:6
  • 5Müller K,Gamba G,Jaquet F,et al.Torasemide vs.furosemidein primary care patients with chronic heart failure NTHAⅡtoⅣ:efficacy and quality of life[J].Eur J Heart Fail,2003,5(6):793-801.
  • 6Veeraveedu PT,Watanabe K,Ma M,et al.Torasemide,a long-acting loop diuretic,reduces the progression of myocarditis todilated cardiomyopathy[J].Eur J Pharmacol,2008,581(1-2):121-131.
  • 7Díez J,Coca A,de Teresa E,et al.TORAFIC study protocol:torasemide prolonged release versus furosemide in patientswith chronic heart failure[J].Expert Rev Cardiovasc Ther,2009,7(8):897-904.
  • 8Asare K.Management of loop diuretic resistance in the inten-sive care unit[J].Am J Health Syst Pharm,2009,66(18):1635-1640.
  • 9陈灏珠.实用内科学[M]第10版[M].北京:人民卫生出版社,1998.1475-1482.
  • 10Diez J, Coca A, de Teresa E, et al. TORAFIC study proto- col: torasemide prolonged release versus furosemide in pa- tients with chronic heart failure [ J ]. Expert Rev Cardiovasc Ther, 2009, 7(8): 897.

共引文献36

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部